| Systemic Lupus Erythematosus |
1 |
1 |
| Lupus |
0 |
0.92 |
| Lupus Nephritis |
0 |
0.67 |
| Cardiovascular Risk Management |
0 |
0.99 |
| Artificial Intelligence |
0 |
0.15 |
| Clinical Guidelines |
0 |
0.15 |
| Hospital |
0 |
0.15 |
| Nephritis |
0 |
0.15 |
| Coronary Artery Disease (CAD) |
0 |
0.11 |
| Cerebrovascular Accident |
0 |
0.09 |
| Biomarker |
0 |
0.08 |
| California |
0 |
0.08 |
| Cardiovascular disease |
0 |
0.08 |
| Face |
0 |
0.08 |
| Glucocorticoid |
0 |
0.08 |
| Infarction |
0 |
0.08 |
| Kidney |
0 |
0.08 |
| Shared Decision-Making |
0 |
0.08 |
| Translational Research |
0 |
0.08 |
| Healthcare and Medical Technology |
0 |
0.06 |
| Myocardial Infarction (MI) |
0 |
0.03 |